Clinical Trial Update: A Phase Ⅱ Clinical Study of Sanhuangjingshimingwan in Wet( Neovascular)Age-related Macular Degeneration(wAMD) Subjects [Phase 2]

View source ↗

Summary

Phase 2 clinical study of Sanhuangjingshimingwan in wet age-related macular degeneration completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Sanhuangjingshimingwan

Snippet

Sponsor: Tasly Pharmaceutical Group Co., Ltd | Conditions: Age-related Macular Degeneration | Phase 2 | Status: COMPLETED